The Postdoctoral Research Fellow, Cancer Research will function under the supervision of Principal Investigator, Kevin Tong. The laboratory investigates molecular mechanisms of colon cancer progression, tumor microenvironment, and cancer drug resistance. Candidate will be responsible for utilizing a combination of mouse models, patient derived organoids (PDO), and bioinformatics to address questions pertinent to cancer progression and metastasis. The candidate should have a Ph.D. in a relevant biological field and must be proficient in general molecular and/or biochemical techniques. Experience in organoid derivation and culture and/or mouse models is highly preferred.
The Center for Discovery and Innovation- CDI was established by Hackensack Meridian Health (HMH) as an academic basic and translational research enterprise to rapidly translate science innovation to the clinic and to improve outcomes for patients with cancer, infectious diseases, autoimmune disease and other acute and chronic diseases. The CDI has grown rapidly since its origins in 2019, and now has 32 labs, 190 scientists and allied personnel supported by 60 NIH grants and more than 30 other grants and contracts. Areas of expertise include genomics, epigenetics, drug resistance, immunology and immunotherapy, stem cell biology, drug discovery, diagnostics and biomarker development, and pharmacology.
A day in the life of a Postdoctoral Research Fellow, Cancer Research at Hackensack Meridian Health includes:
Education, Knowledge, Skills and Abilities Required:
Education, Knowledge, Skills and Abilities Preferred:
If you feel that the above description speaks directly to your strengths and capabilities, then please apply today!
Software Powered by iCIMS
www.icims.com